Scripps Research Institute

Total Awards: 
Approved funds: 
Institution type: 
Not for profit

Awards to the Institution

Early Translational III: Peter Schultz Targeting Stem Cells to Enhance Remyelination in the Treatment of Multiple Sclerosis $4,327,175
Transplantation Immunology: Jeanne Loring Thymus based tolerance to stem cell therapies $1,269,844
Shared Labs: Jeanne Loring Center for hESC Research $5,216,885
Early Translational I: Jeanne Loring Ensuring the safety of cell therapy: a quality control pipeline for cell purification and validation $6,292,290
Early Translational I: Martin Friedlander Autologous Retinal Pigmented Epithelial Cells Derived from Induced Pluripotent Stem Cells for the Treatment of Atrophic Age Related Macular Degeneration $5,945,738
Early Translational II: Peter Schultz Cartilage Regeneration by the Chondrogenic Small Molecule PRO1 during Osteoarthritis $6,792,660
New Faculty I: Kristin Baldwin Generating pluripotent cell lines from neurons. $2,803,375
Basic Biology III: Kristin Baldwin Identifying sources of mutation in human induced pluripotent stem cells by whole genome sequencing $1,755,864
Research Training II: Ulrich Mueller Training Stem Cell Researchers at the Chemistry-Biology Interface $4,058,362
Training Grant I-2: Peter Schultz Training Grant I $1,059,300
Creativity Awards: James Williamson Stem Cell Summer Academy: Creating the Next Generation of Scientists $206,250
SEED Grant: Peter Schultz A Chemical Approach to Stem Cell Biology $784,900
Tools and Technologies I: Carlos Barbas Development of a novel technology for precise, efficient, and safe genetic modification of stem cells $1,146,312
Tools and Technologies I: Jeanne Loring The Stem Cell Matrix: a map of the molecular pathways that define pluripotent cells $1,141,124
Transplantation Immunology: Nicholas Gascoigne Role of Innate Immunity in hematopoeitic stem cell-mediated allograft tolerance $1,746,684
Basic Biology III: Joel Gottesfeld Triplet Repeat Instability in Human iPSCs $1,755,861
Icon for xls export

© 2013 California Institute for Regenerative Medicine